Cyanophyta Aphanizomenon Flos-aquae, and Adipose Stroma Vascular Fraction, in Heart Failure Patient

Congestive Heart Failure Chronic Clinical Trial

Official title: The Effect of Cyanophyta Aphanizomenon Flos-aquae (Stemregen), and Adipose Stroma Vascular Fraction (SVF) Either Individual or in Combination in Patient With Heart Failure

Status Recruiting

Clinical Trial Summary

This study is a prospective, randomized, controlled trial to assess the efficacy of transplantation of autologous stroma vauscultar fraction and/or AFA in 15 patients with ischemic heart failure

Clinical Trial Description

Stem cells therapy may be a choice therapy for advanced heart failure patients refractory to medical therapy, and a previous history of coronary artery diseases. In this study the investigators have evaluated consecutive 15 selected patients, the amelioration in failing heart NYHA class, hospitalization rate, echocardiographic left ventricle functionality, serum of Natriuretic peptide level and associated to reduction of angina after a treatment with stroma vascular fraction infusion y/or Stemregen capsule per oral. ;

Related Conditions & MeSH terms

• Congestive Heart Failure Chronic
• Heart Failure

• NCT number: NCT04515537
• Study type: Observational
• Source: Sociedad Española de Medicina Regenerativa y Terapia Celular
• Contact: Miguel G Garber, MD
• Phone: 34 628766753
• Email: mggarber@gmail.com
• Status: Recruiting
• Start date: May 20, 2021
• Completion date: September 30, 2023